Cytta Corp Stock Price To Earnings To Growth
| CYCA Stock | USD 0.02 0 16.40% |
Cytta Corp fundamentals help investors to digest information that contributes to Cytta Corp's financial success or failures. It also enables traders to predict the movement of Cytta OTC Stock. The fundamental analysis module provides a way to measure Cytta Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cytta Corp otc stock.
Cytta |
Cytta Corp OTC Stock Price To Earnings To Growth Analysis
Cytta Corp's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Cytta Corp has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Health Care Technology sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Cytta Fundamentals
| Return On Equity | -7.68 | |||
| Return On Asset | -2.89 | |||
| Operating Margin | (829.72) % | |||
| Current Valuation | 34.94 M | |||
| Shares Outstanding | 383.69 M | |||
| Shares Owned By Insiders | 29.32 % | |||
| Price To Earning | (0.29) X | |||
| Price To Book | 26.57 X | |||
| Price To Sales | 1,265 X | |||
| Revenue | 6.09 K | |||
| Gross Profit | 6.09 K | |||
| EBITDA | (5 M) | |||
| Net Income | (5.1 M) | |||
| Cash And Equivalents | 1.57 M | |||
| Total Debt | 438.1 K | |||
| Current Ratio | 3.61 X | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (2.38 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 13 | |||
| Beta | 0.73 | |||
| Market Capitalization | 15.35 M | |||
| Total Asset | 911.01 K | |||
| Retained Earnings | (7.33 M) | |||
| Working Capital | (440 K) | |||
| Current Asset | 20 K | |||
| Current Liabilities | 460 K | |||
| Z Score | -6.7 | |||
| Net Asset | 911.01 K |
About Cytta Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cytta Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cytta Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cytta Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Cytta OTC Stock
Cytta Corp financial ratios help investors to determine whether Cytta OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cytta with respect to the benefits of owning Cytta Corp security.